At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment.
As part of our commitment to our clients, their customers, and their patients, we intentionally seek out and acquire best-in-class agencies that can help us further our services. Our ambitious growth strategy plays a crucial role in helping us to achieve our mission of improving access and empowering healthcare professionals and patients with the knowledge needed to save lives.
Today, our clients are looking for bold collaboration and digital, data-driven, solutions that meet patient and healthcare professional needs in a new world. And that’s why we are excited to welcome Chicago-based closerlook LLC to our pack.
closerlook is a digital-native healthcare agency that leverages artificial intelligence (AI) and data analytics to develop omnichannel strategies, creative, and digital media solutions for life science brands across the entire pre-commercial and commercial lifecycle of a drug.
closerlook’s skills and software products in data science, AI, and advanced analytics provide life science brands with real-time insights and the ability to develop hyper-targeted and precisely personalized campaigns at scale.
When combined with Fishawack Health’s existing omnichannel services, which span medical communications, commercial, and consulting capabilities, life science companies will have the opportunity to access and benefit from an unrivaled offering that will help them precisely understand and engage stakeholders.
The firm’s approach to data-driven healthcare marketing is powered by its four capabilities: omnichannel strategy, conceptual creative and content, digital tactics and media management, and advanced analytics, each of which is informed by Backstage® Intelligence, the firm’s proprietary data and intelligence marketing hub.
The platform uses AI and data science to inform and precisely tailor healthcare professional and patient experiences, providing healthcare marketers with unrivaled access to an integrated platform, designed for competitive advantage.
Biopharma companies can use these insights to engage with customers and patients in novel and intelligent ways, driving innovation and connecting healthcare professionals and patients with the knowledge they need to improve health outcomes and live better lives.
The company works with a range of innovative biopharma companies including UCB, Novo Nordisk, Astellas, Akebia, TerSera Therapeutics, Zogenix, BioMarin, and argenx. Its clients benefit from the team’s deep expertise in specialty, oncology, and rare disease therapy areas, as well as in autoimmune and renal diseases, endocrinology, and rheumatology. closerlook’s experiences complement our broad healthcare expertise derived from partnering with all of the top 20 pharma companies, supporting 30 rare disease products across our client roster, and successfully launching 100+ new products, supported by150+ PhDs engaged full-time on the team.
In 2021 alone, closerlook has been nominated for several awards including Winner, Unbranded: Pharma at the Brand Film Awards, co-hosted by MM+M; Finalist, Best Launch Campaign at the MedAd News Manny Awards; and Finalist, Agency of the Year, Category II at the MedAd News Manny Awards, an accolade which complements Fishawack Health’s nomination for Network of the Year.
What the leaders said:
Oliver Dennis, Fishawack Health co-founder and CEO, said: “Traditionally, the healthcare sector has fallen behind when it comes to leveraging the power of innovative technologies and data to enhance commercial and medical communications strategies. The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings. Life science brands need a new breed of partner that offers bespoke teams who bring with them digital and analytics prowess, a rigorous understanding of the science, and the ability to develop impactful strategies and creative solutions.”
“closerlook’s advanced AI and analytics offering can track and optimize performance, delivering increased business results for clients. Through this combination of expertise, we can develop highly intelligent solutions that are integral for developing, launching and growing brands and portfolios in a complex and crowded marketplace.”
David Ormesher, CEO of closerlook, reveals: “We are energized by the prospect of joining a global team with the breadth and depth of Fishawack Health. I believe that the combination of our AI/advanced analytics-enabled omnichannel strategy, creative, and digital media with Fishawack Health’s global consulting, commercial and medical communications capabilities will create a unique commercialization offering for life science brands and healthcare companies looking for growth.
“We have spent over six months getting to know the Fishawack Health leadership, and we are excited about the alignment of vision, purpose, and culture between our two organizations. Over the past year, closerlook has experienced the fastest growth in its history and we expect Fishawack Health to supercharge that even more. We are looking forward to working together to achieve our mission of better health outcomes for patients and greater business results for the biopharma brands that serve them”.
Fishawack Health Group President Gail Flockhart said: “We are delighted to welcome closerlook to Fishawack Health, including their impressive and experienced management team who will no doubt play an important role in helping us further enhance our capabilities and services across the group.”
To find out more about our digital expertise, contact email@example.com
Want to learn more about digital health trends? Download Delta magazine